International (Asia Pacific)

APSIC Revised Guidelines for Prevention of Central Line Associated Bloodstream Infections (CLABSI) 2024

129 controls. 0 other frameworks in our corpus share controls with it. Here is all of it, and how much of it you are already doing.

Page built . This page is derived from the framework corpus, which changes when the corpus is extended rather than daily.

129 controls 0 frameworks share controls with it International (Asia Pacific) verified against its source document

Every control below is one this framework asks for. The right hand column counts how many other frameworks in our corpus carry the same control, which is the difference between doing this work once and doing it again for the next standard.

There is no implementation kit for this framework yet. The control list and the overlap above are free and complete.

What you already have

Frameworks whose controls overlap this one, most first. If you run any of them, the count is roughly what you have already evidenced.

No measured overlap with another framework in the corpus.

Every control

CodeControlAlso in
INTRO-01Central line use and CLABSI burden0
INTRO-02Definition of CLABSI0
INTRO-03Routes of catheter contamination0
INTRO-04CLABSI incidence and burden0
INTRO-05Patient and care risk factors0
INTRO-06Insertion and maintenance bundles0
INTRO-07Insertion bundle elements0
INTRO-08Maintenance bundle elements0
INTRO-09Daily review of line need0
INTRO-10Replace line after emergency insertion breach0
INTRO-11Guidewire exchange decisions0
INTRO-12Daily catheter site and patency checks0
INTRO-13Hand hygiene and aseptic technique for CVC care0
INTRO-14Hub disinfection before access0
INTRO-15Dressing selection and skin preparation0
INTRO-16Dressing replacement intervals0
INTRO-17CHG dressing for short-term catheters0
INTRO-18Catheter site monitoring0
INTRO-19Administration set replacement0
INTRO-20Long term central venous catheter types0
INTRO-21Care of hemodialysis catheter at home0
INTRO-22Model for improvement0
INTRO-23Teamwork in CLABSI prevention0
INTRO-24Culture of zero tolerance0
INTRO-25Education and training0
INTRO-26Cost effectiveness analysis0
INTRO-27Economic evaluation of IPC programmes0
INTRO-28Barriers to CLABSI prevention implementation0
INTRO-29Additional strategies for high-rate units0
INTRO-30Antiseptic barrier caps for catheter hubs0
INTRO-31rt-PA for dialysis catheter thrombosis0
INTRO-32Topical antimicrobial ointment at exit sites0
INTRO-33Consistent methods and process measures0
INTRO-34CLABSI rate per 1000 central line days0
INTRO-35Central line utilization ratio as a quality marker0
INTRO-36Insertion bundle adherence rate calculation0
INTRO-37Components needed for a yes on adherence0
INTRO-38Random and special cause variation0
INTRO-39Counting data runs on the chart0
INTRO-40Counting useful observations0
INTRO-41Spotting a shift from a long run0
INTRO-42Spotting a trend0
INTRO-43Monthly rates, feedback and committee reporting0
S1.1CLABSI education and training resources0
S1.2Staff and patient competence0
S1.3Minimum catheter ports and lumens0
S1.4Minimum catheter dwell time0
S10.1Skill development and competency testing0
S10.2Evaluate education program impact0
S11.1Cost-effectiveness analysis to justify IPC resources0
S12.1Remove barriers to IPC adherence0
S13.1Daily CHG bathing for ICU patients over 2 months0
S14.1Impregnated CVCs for expected dwell over 7 days0
S14.2Monitor patients for impregnated catheter side effects0
S15.1aAntimicrobial lock for long-term haemodialysis catheters0
S15.1bLock solution with limited venous access and recurrent CLABSI0
S15.1cLock solution for paediatric cancer patients0
S16.1Sutureless securement for central venous catheters0
S17.1Split septum valve preferred over mechanical valves0
S17.2Disinfect access ports before every access0
S17.3Compatible needleless components0
S17.4Change needleless components with administration sets0
S17.5Needleless connector change interval0
S17.6Needleless system for IV tubing access0
S18.1Antiseptic cap over every connector0
S19.1Weekly rt-PA lock after dialysis0
S2.1aSite choice balances infection and mechanical risk0
S2.1bAvoid femoral access in obese adults0
S2.1cSubclavian site in adult ICU0
S2.1dUpper body site in adult non-ICU0
S2.1eUltrasound for internal jugular insertion0
S2.1fTunneled CVC site unresolved0
S2.1gJugular or femoral access for dialysis and pheresis0
S2.1hUltrasound to improve insertion success0
S2.2Hand hygiene around catheter care0
S2.3Sterile gloves for catheter insertion0
S2.4New sterile gloves for guidewire exchange0
S2.5Chlorhexidine skin antisepsis0
S2.6Disinfect catheter hubs and ports0
S2.7Maximal sterile barriers0
S2.8Chlorhexidine dressings for children over 2 months0
S2.9Dressing for moisture or oozing blood0
S20.1No antibiotic ointment except on dialysis catheters0
S20.2Povidone iodine or triple antibiotic ointment on dialysis exit sites0
S20.3Mupirocin kept off insertion sites0
S21.1Choose the population under surveillance0
S21.2Method for collecting denominator data0
S21.3Regular laboratory notification of positive cultures0
S21.4Apply LCBI criteria to each positive culture0
S21.5Calculate the CLABSI rate0
S22.1Population for insertion bundle audit0
S22.2Record adherence for every insertion0
S22.3Who records bundle adherence0
S3.1Trained and competent catheter staff0
S3.10Change chlorhexidine dressings every 7 days0
S3.11Replace continuous administration sets every 7 days0
S3.12Replace propofol tubing every 6 or 12 hours0
S3.2Prompt removal of unnecessary catheters0
S3.3Replace emergency catheters within 48 hours0
S3.4Avoid routine catheter replacement0
S3.5Glove use for dressing changes0
S3.6Change antiseptic barrier caps after access0
S3.7Change administration sets every 7 days0
S3.8Disinfect access hubs before use0
S3.9Sterile dressing for catheter site0
S4.a1Aseptic technique during catheter access0
S4.a2Hand hygiene around central line access0
S4.a3Scrub access devices for 3 to 5 seconds0
S4.a4Sterile connection to catheter lumen0
S4.b1Hand hygiene before preparing infusions0
S4.b2Aseptic technique for parenteral procedures0
S4.b3Chlorhexidine dressings for patients over 2 months0
S4.b4Flush unused long term catheters0
S4.b5Single patient infusion supplies0
S4.b6Time limits for lipid and blood infusions0
S5.1Antimicrobial lock therapy for long term catheters0
S5.2Weekly rt-PA after hemodialysis0
S5.3Antimicrobial ointment at hemodialysis sites0
S5.4Antiseptic caps for catheter connectors0
S6.1Hand hygiene before home dialysis care0
S6.2Avoid touching the catheter exit site0
S6.3Keep home catheter dressing intact0
S6.4Clothing that protects vascular access0
S6.5Masks during hemodialysis line connection0
S7.1Quality improvement approach for bundles0
S8.1Multidisciplinary team for catheter care0
S8.2Share data and act on it0
S9.1Leadership support for zero tolerance0
S9.2Accountability from board to frontline0

Tell me when APSIC Revised Guidelines for Prevention of Central Line Associated Bloodstream Infections (CLABSI) 2024 files something new

One email when a public company newly discloses something this framework governs, naming the company and what our corpus says it puts in scope. Nothing else, and one click to stop.

What this page is

A control-level reference for APSIC Revised Guidelines for Prevention of Central Line Associated Bloodstream Infections (CLABSI) 2024, drawn from our framework corpus. Control codes and titles are references to the standard, not reproductions of it. The overlap counts and the auditor artefacts are our own work and are the part you will not find elsewhere.

Measure this against what you already run · All frameworks · Today's edition